中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2008年
10期
17-18
,共2页
SCTA%胰腺癌%可切除性
SCTA%胰腺癌%可切除性
SCTA%이선암%가절제성
Spiral CT angiography%Pancreatic cancer%Resectability
目的 探讨螺旋CT血管造影(SCTA)诊断胰腺癌胰周血管侵犯及评价可切除性的价值.方法 10例疑有局部浸润的胰腺癌患者术前行横断面CT及螺旋CT血管造影检查.比较分析SCTA与横断面CT诊断肿瘤侵犯胰周血管情况以及评价肿瘤可切除性.结果SCTA诊断胰周血管侵犯的敏感度、阴性预测值(100%、100%)高于横断面CT(81.8%、92.6%).两者差异有统计学意义(P<0.05).SCTA术前评价胰腺癌可切除性的阳性预测值高于横断面CT.结论 SCTA可精确地诊断胰腺癌侵犯胰周血管的情况,术前可准确评价胰腺癌可切除性.
目的 探討螺鏇CT血管造影(SCTA)診斷胰腺癌胰週血管侵犯及評價可切除性的價值.方法 10例疑有跼部浸潤的胰腺癌患者術前行橫斷麵CT及螺鏇CT血管造影檢查.比較分析SCTA與橫斷麵CT診斷腫瘤侵犯胰週血管情況以及評價腫瘤可切除性.結果SCTA診斷胰週血管侵犯的敏感度、陰性預測值(100%、100%)高于橫斷麵CT(81.8%、92.6%).兩者差異有統計學意義(P<0.05).SCTA術前評價胰腺癌可切除性的暘性預測值高于橫斷麵CT.結論 SCTA可精確地診斷胰腺癌侵犯胰週血管的情況,術前可準確評價胰腺癌可切除性.
목적 탐토라선CT혈관조영(SCTA)진단이선암이주혈관침범급평개가절제성적개치.방법 10례의유국부침윤적이선암환자술전행횡단면CT급라선CT혈관조영검사.비교분석SCTA여횡단면CT진단종류침범이주혈관정황이급평개종류가절제성.결과SCTA진단이주혈관침범적민감도、음성예측치(100%、100%)고우횡단면CT(81.8%、92.6%).량자차이유통계학의의(P<0.05).SCTA술전평개이선암가절제성적양성예측치고우횡단면CT.결론 SCTA가정학지진단이선암침범이주혈관적정황,술전가준학평개이선암가절제성.
Objective The purpose of this study was to test the role of Spiral CT Angiogrsphy(SCTA)to predict vascular involvement from pancreatic cancer and the resectability of pancreatic tumors.Methods SCTA and axial CT scans were done to 10 patients who had adenocarcinoma of the pancreas.Of these patients 9 underwent radical surgery,vessel integrity of the superior mesenteric,superior mesenteric vein,and portal vein and cavum artery was assessed prospectively on both axial CT scans and SCTA.ResultsSpiral CT angiograms were obtained in all patients.Compared with axial CT images.SCTA was more accurate at revealing vessel encasement.The sensitivity and the negative predictive value of vessel encasement was both 100% for SCTA compared with 81.8%and 92.6%for axial CT images(P<0.05).The positive predictive value of a resectable tumor was 100%for SCTA compared with 83.3%for axial helical CT images.Conclusions Spiral CT angiography of the pancreas provides useful information about local vascular invdvemem from pancreatic carcinoma.Compared with convenriohal axial CT scans,SCTA improves surgeons'ability to predict the resectability of pancreatic tumors.